Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueGross MarginNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Pharming (PHAR) Assets Average (2021 - 2025)

Historic Assets Average for Pharming (PHAR) over the last 5 years, with Q3 2025 value amounting to $460.0 million.

  • Pharming's Assets Average rose 934.13% to $460.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $460.0 million, marking a year-over-year increase of 934.13%. This contributed to the annual value of $431.4 million for FY2024, which is 290.46% down from last year.
  • Latest data reveals that Pharming reported Assets Average of $460.0 million as of Q3 2025, which was up 934.13% from $424.7 million recorded in Q2 2025.
  • Pharming's 5-year Assets Average high stood at $413.3 billion for Q1 2021, and its period low was $196.6 million during Q1 2022.
  • For the 5-year period, Pharming's Assets Average averaged around $53.3 billion, with its median value being $426.4 million (2023).
  • Data for Pharming's Assets Average shows a peak YoY increase of 9526747.47% (in 2022) and a maximum YoY decrease of 9995.24% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows Pharming's Assets Average stood at $200.7 million in 2021, then skyrocketed by 95267.47% to $191.4 billion in 2022, then plummeted by 99.77% to $449.7 million in 2023, then fell by 8.21% to $412.7 million in 2024, then rose by 11.45% to $460.0 million in 2025.
  • Its Assets Average was $460.0 million in Q3 2025, compared to $424.7 million in Q2 2025 and $401.6 million in Q1 2025.